US patient with MERS is improving: health officials

The first US patient sickened by the dangerous Middle East respiratory virus, MERS, is doing better and no other cases have emerged, American health officials said Monday.

The patient, a male healthcare worker who came down with the illness while working in Saudi Arabia, is still hospitalized and in isolation but is improving, officials told reporters.

"We expect him to be going home soon," said Alan Kumar, chief medical information officer at Community Hospital in Munster, Indiana.

MERS, short for Middle East respiratory syndrome coronavirus, is a concern to authorities because even though it is harder to transmit than the flu, it is often deadly.

It first emerged in Saudi Arabia in 2012, and has since infected hundreds of people in 12 countries.

Symptoms include fever, cough and shortness of breath. About 30 percent of cases have been fatal, particularly among elderly people and those with pre-existing health problems.

The Indiana patient is believed to have acquired MERS while working in a healthcare setting in Riyadh, where other patients with MERS were present, though he was not working specifically with them, officials said.

He then traveled by plane to London and Chicago, where he boarded a public bus toward Indiana. On April 28, he went to the emergency room and tests confirmed he had MERS on May 2.

Travelers contacted

The Centers for Disease Control and Prevention obtained the manifest of travelers on the plane, which included about 100 people. About 10 passengers were on the bus, said Daniel Feikin, the lead medical epidemiologist from the CDC.

"So far almost three-quarters of the travelers have been contacted and to date none of them have been symptomatic," he said.

In addition about 50 healthcare workers who came near the patient before it was known that he had MERS have tested negative for the virus.

Since symptoms can take up to 14 days to occur, experts are being "very vigilant" and repeat tests will be done to confirm that they have not been infected in the coming days, Feikin said.

In the meantime, family members of the man—whose identity and age were not released—and staff members at the hospital who had direct contact with him have been placed in temporary home isolation.

There is no vaccine to prevent MERS and no cure for the lung infection it causes. Some research has suggested it may be crossing from camels into humans.

Last week, Egypt recorded its first infection, after a person who had arrived from Saudi Arabia tested positive.

Meanwhile, Saudi health authorities said Monday that 115 people have died from the MERS coronavirus in the two years since the respiratory disease first appeared in the kingdom.

The country's number of MERS infections has meanwhile risen to 414, the world's highest tally, the ministry reported.

The World Health Organization is working to confirm more cases, but as of Monday the official global tally was 401 confirmed cases of MERS-CoV infection, with 93 deaths, according to the CDC.

MERS is not as contagious as SARS, the that emerged in 2003 and infected thousands of people across Asia.

Rather, MERS is transmitted by close contact among people in the same household or in a healthcare setting, officials said.

The CDC urges people who develop fever and cough within two weeks of traveling to Saudi Arabia to report to their doctor for testing.

Otherwise, people can reduce their risk of infection by washing hands often, covering their nose and mouth when sneezing, avoid sharing of cups or utensils with sick people and disinfecting toys and doorknobs.

© 2014 AFP

Citation: US patient with MERS is improving: health officials (2014, May 5) retrieved 23 April 2024 from https://medicalxpress.com/news/2014-05-patient-mers-health.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Saudi MERS death toll reaches 115

 shares

Feedback to editors